Home/Filings/4/0001593968-19-000563
4//SEC Filing

CARLO DENNIS J PHD 4

Accession 0001593968-19-000563

CIK 0000887247other

Filed

Feb 24, 7:00 PM ET

Accepted

Feb 25, 7:10 PM ET

Size

8.8 KB

Accession

0001593968-19-000563

Insider Transaction Report

Form 4
Period: 2019-02-21
CARLO DENNIS J PHD
DirectorPresident/CEO10% Owner
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2019-02-21+27,82255,645 total
    Common Stock (27,822 underlying)
  • Exercise/Conversion

    Common Stock

    2019-02-21+27,822388,883 total
Holdings
  • Common Stock

    (indirect: By Trust)
    250,709
  • Common Stock

    (indirect: By Children)
    5,883
Footnotes (3)
  • [F1]Represents the vesting of a portion of previously granted restricted stock units (RSU), with shares of common stock to be issued following vesting of the RSUs as described in the award agreement relating to the RSUs.
  • [F2]Includes common stock, as well as restricted stock units granted on January 30, 2019, to the reporting person and previously reported on a Form 4.
  • [F3]On February 21, 2018, the reporting person was granted 83,467 restricted stock units. 1/3 of the Restricted Stock Units vest on each anniversary of the grant date over a three year period provided that the Reporting Person has continued to provide services to the Company during such period.

Issuer

Adamis Pharmaceuticals Corp

CIK 0000887247

Entity typeother

Related Parties

1
  • filerCIK 0001038322

Filing Metadata

Form type
4
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 7:10 PM ET
Size
8.8 KB